US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 0.2600
  • +0.0299+12.99%
15min DelayTrading Apr 9 13:07 ET
323.05KMarket Cap0.00P/E (TTM)

Virpax Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-69.61%-16.71M
4.68%-2.87M
-68.59%-4.47M
24.71%-1.64M
-284.86%-7.73M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
Net income from continuing operations
20.56%-12.07M
25.68%-3.39M
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
Change In working capital
-199.78%-4.78M
-67.16%512.2K
-177.67%-2.45M
143.70%1.73M
-629.08%-4.58M
56.62%4.79M
21.72%1.56M
57.98%3.15M
-21.29%711.59K
43.85%-628.42K
-Change in prepaid assets
131.96%444.28K
0.01%398.6K
6.39%278.72K
51.62%544.4K
6.11%-777.44K
-90.67%191.53K
-83.36%398.56K
-2.31%261.97K
-40.90%359.06K
32.04%-828.07K
-Change in payables and accrued expense
29.35%775.35K
-29.57%113.6K
-96.24%-223.81K
237.49%1.19M
-252.36%-304.18K
160.36%599.43K
105.18%161.3K
-106.61%-114.05K
18.90%352.53K
101.26%199.65K
-Change in other current liabilities
-250.00%-6M
--0
-183.33%-2.5M
--0
---3.5M
100.00%4M
-50.00%1M
--3M
--0
--0
Cash from discontinued investing activities
Operating cash flow
-69.61%-16.71M
4.68%-2.87M
-68.59%-4.47M
24.71%-1.64M
-284.86%-7.73M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
9.08M
4.37M
2.62M
1.65M
453.95K
0
0
0
0
0
Net common stock issuance
--6.32M
--4.07M
--0
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--2.77M
--68
--2.77M
----
----
--0
--0
--0
----
----
Net other financing activities
----
----
---151.3K
---601.8K
--453.95K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--9.08M
--4.37M
--2.62M
--1.65M
--453.95K
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-51.87%9.14M
-99.86%17.23K
-87.36%1.87M
-89.01%1.87M
-51.87%9.14M
-48.44%19M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
-48.44%19M
Current changes in cash
22.58%-7.63M
149.67%1.5M
30.08%-1.85M
100.21%4.6K
-262.25%-7.28M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
End cash Position
-83.45%1.51M
-83.45%1.51M
-99.86%17.23K
-87.36%1.87M
-89.01%1.87M
-51.87%9.14M
-51.87%9.14M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
Free cash flow
-69.61%-16.71M
4.68%-2.87M
-68.59%-4.47M
24.71%-1.64M
-284.86%-7.73M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -69.61%-16.71M4.68%-2.87M-68.59%-4.47M24.71%-1.64M-284.86%-7.73M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M
Net income from continuing operations 20.56%-12.07M25.68%-3.39M66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M
Change In working capital -199.78%-4.78M-67.16%512.2K-177.67%-2.45M143.70%1.73M-629.08%-4.58M56.62%4.79M21.72%1.56M57.98%3.15M-21.29%711.59K43.85%-628.42K
-Change in prepaid assets 131.96%444.28K0.01%398.6K6.39%278.72K51.62%544.4K6.11%-777.44K-90.67%191.53K-83.36%398.56K-2.31%261.97K-40.90%359.06K32.04%-828.07K
-Change in payables and accrued expense 29.35%775.35K-29.57%113.6K-96.24%-223.81K237.49%1.19M-252.36%-304.18K160.36%599.43K105.18%161.3K-106.61%-114.05K18.90%352.53K101.26%199.65K
-Change in other current liabilities -250.00%-6M--0-183.33%-2.5M--0---3.5M100.00%4M-50.00%1M--3M--0--0
Cash from discontinued investing activities
Operating cash flow -69.61%-16.71M4.68%-2.87M-68.59%-4.47M24.71%-1.64M-284.86%-7.73M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 9.08M4.37M2.62M1.65M453.95K00000
Net common stock issuance --6.32M--4.07M--0----------0--0--0--------
Proceeds from stock option exercised by employees --2.77M--68--2.77M----------0--0--0--------
Net other financing activities -----------151.3K---601.8K--453.95K--------------------
Cash from discontinued financing activities
Financing cash flow --9.08M--4.37M--2.62M--1.65M--453.95K--0--0--0--0--0
Net cash flow
Beginning cash position -51.87%9.14M-99.86%17.23K-87.36%1.87M-89.01%1.87M-51.87%9.14M-48.44%19M-40.90%12.15M-43.20%14.8M-44.84%16.99M-48.44%19M
Current changes in cash 22.58%-7.63M149.67%1.5M30.08%-1.85M100.21%4.6K-262.25%-7.28M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M
End cash Position -83.45%1.51M-83.45%1.51M-99.86%17.23K-87.36%1.87M-89.01%1.87M-51.87%9.14M-51.87%9.14M-40.90%12.15M-43.20%14.8M-44.84%16.99M
Free cash flow -69.61%-16.71M4.68%-2.87M-68.59%-4.47M24.71%-1.64M-284.86%-7.73M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More